Inventor · disambiguated record
Nagamani Nagabhushan
Also filed as: NAGABHUSHAN NAGAMANI
10 granted patents·2 pending applications·581 citations·filing 1993–2009
94Inventor score
Files withSCHERING CORP12
Top patents by PatentIndex Score
12 records- 0196US6057307AUse of mometasone furoate for treating airway passage and lung diseasesSCHERING CORP·Filed 1999·Granted May 2, 2000·118 cites·29 claims
- 0296US5889015AUse of mometasone furoate for treating lower airway passage and lung diseasesSCHERING CORP·Filed 1997·Granted Mar 30, 1999·124 cites·35 claims
- 0396US5837699AUse of mometasone furoate for treating upper airway passage diseasesSCHERING CORP·Filed 1997·Granted Nov 17, 1998·125 cites·21 claims
- 0494US6677323B2Use of mometasone furoate for treating airway passage and lung diseasesSCHERING CORP·Filed 2002·Granted Jan 13, 2004·33 cites·14 claims
- 0594US6677322B2Use of mometasone furoate for treating airway passage and lung diseasesSCHERING CORP·Filed 2002·Granted Jan 13, 2004·36 cites·15 claims
- 0694US6365581B1Use of mometasone furoate for treating airway passage and lung diseasesSCHERING CORP·Filed 2000·Granted Apr 2, 2002·34 cites·25 claims
- 0792US6723713B2Use of mometasone furoate for treating upper airway diseasesSCHERING CORP·Filed 2003·Granted Apr 20, 2004·26 cites·10 claims
- 0888US5441734AMetal-interferon-alpha crystalsSCHERING CORP·Filed 1993·Granted Aug 15, 1995·71 cites·23 claims
- 0983US6949532B2Use of mometasone furoate for treating airway passage and lung diseasesSCHERING CORP·Filed 2004·Granted Sep 27, 2005·8 cites·17 claims
- 1080US6956030B2Use of mometasone furoate for treating upper airway diseasesSCHERING CORP·Filed 2004·Granted Oct 18, 2005·6 cites·9 claims
- 1172US2010022493A1Use of mometasone furoate for treating airway passage and lung diseaseSCHERING CORP·Filed 2009·Application pending·0 cites
- 1261US2005287080A1Use of mometasone furoate for treating airway passage and lung diseaseSCHERING CORP·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →